Direct answer: build the case around coordination, not clinical novelty

A care network business case for getpulse.care should show that patient-pulse and care-coordination software helps a clinic, provider group, or health system connect fragmented care while reducing avoidable operational work. The strongest case is not that software can diagnose patients or replace clinicians; that promise would create procurement, safety, and regulatory problems. It is that authorized teams can identify missed follow-ups, monitor whether care plans are being completed, detect operational bottlenecks, and make limited staff time available for higher-value patient work.

Also worth reading: How Can Clinics Measure Patient Coordination ROI Beyond Automated Tasks? · How Can Clinics Optimize Referral Processes Without Losing Patient Continuity? · How Should Clinics Validate Patient Messaging Releases Before Sending?

The financial argument should use the buyer’s existing data rather than generic savings claims. A network may estimate staff hours spent on referrals, status requests, outreach, and report preparation, then price that time at fully loaded hourly cost. It can also measure empty appointments, delayed transitions of care, preventable utilization, and patient leakage using the organization’s own baseline. A credible business case normally requires at least two measurable use cases, a named operational owner, a 6–12 month pilot, and explicit rules for renewal or cancellation.

For a B2B care-coordination platform, the decision should be framed as a service-improvement investment with evidence gates, not as a guaranteed return. As of 26 September 2026, buyers should expect security reviews, integration analysis, clinical governance, and workflow design to account for much of the launch effort. A platform that cannot produce auditable actions, support role-based access, and demonstrate measurable adoption should not receive a broad rollout.

Define the operating problem and who pays

Start by separating patient-pulse measurement from care-network coordination. A patient pulse can combine check-ins, reported outcomes, symptoms, adherence signals, service-experience feedback, and operational status, but only where patients can decline without affecting access to care. Care coordination adds the workflow around that information: assigning follow-ups, documenting outreach, recording closed-loop status, escalating exceptions, and reporting results to clinics or network partners. Without that workflow, dashboards tend to become passive reports that managers view but do not use.

The economic buyer may be a clinic executive, medical affairs leader, quality team, care-management director, or shared-services leader. The person operating the software may instead be a care manager, population-health nurse, referral coordinator, practice manager, or administrator. Identifying both roles prevents a common mistake in which the information technology department approves a tool that frontline staff cannot fit into a 10-minute workflow. Financial benefit may appear in several departments, so one accountable sponsor should own the business case even if operational and technical stakeholders contribute to it.

A useful problem statement contains four quantities: the number of patients or episodes under consideration, the current completion rate for the required action, the average staff time per incomplete action, and the financial or clinical consequence of noncompletion. For example, if 2,000 patients need post-discharge outreach, current completion is 62%, and each outreach attempt takes 12 minutes, the gap is 760 attempted contacts before rework. Those figures should be validated during discovery rather than accepted as vendor estimates, and local labor costs should replace invented industry-wide rates.

Quantify value with conservative, auditable metrics

A business case should convert activity into value using a baseline, target, measurement method, time horizon, and attribution rule. A simple productivity formula is hours recovered multiplied by loaded hourly cost, but it should be adjusted for adoption and only count time the organization confirms is actually avoided or redirected. A stronger case also separates gross capacity from realized value: reducing eight hours of work per coordinator does not automatically produce eight hours of cost savings if that capacity cannot be removed, reassigned, or used to reduce a documented backlog.

Patient-level value is more difficult to attribute and should be presented as a measured hypothesis rather than a promise. Organizations can track seven-day follow-up completion, referral closure, time to first contact, care-plan completion, no-show rates, emergency-department use within 30 days, and readmission within 30 or 90 days. Improvement should be compared with an appropriate baseline and, when feasible, a matched group, because simultaneous quality initiatives can distort results. A 10% improvement in a metric with weak baseline controls is less persuasive than a 5% improvement supported by reliable data and clinician review.

Use three financial categories in the proposal: hard savings, avoided future cost, and strategic capacity. Hard savings might include retired duplicate licenses, reduced overtime, or lower manual-reporting effort. Avoided future cost can include fewer denied claims or reduced avoidable utilization, although attribution may take longer and require actuarial or clinical validation. Strategic capacity, such as better triage visibility, can still be valuable, but it should not be presented as cash unless leadership can define how it changes staffing, throughput, access, or revenue. Transparent ranges are more credible than one optimistic point estimate.

Compare software, staffing, and hybrid operating models

Care networks have alternatives beyond purchasing a dedicated platform. They can add staff, use existing electronic health record messaging, deploy a general-purpose survey product, create internal scripts and spreadsheets, or combine a communication tool with a narrowly focused workflow. These options have different strengths. They may be cheaper for a single clinic, while dedicated software becomes more useful when several teams need shared definitions, escalation rules, dashboards, and consistent execution across organizational boundaries.

The comparison should evaluate the whole operating model, including implementation, training, maintenance, reporting, and integration. A staffing approach may provide more judgment and relationship context, but it can scale unevenly and make performance difficult to audit. An existing electronic health record module may reduce integration friction, but it is often designed around clinical transactions rather than ongoing outreach, longitudinal patient feedback, and cross-team accountability. A custom-built system offers maximum control but creates a permanent engineering and support burden.

FeatureStandalone patient-pulse and coordination SaaSExisting EHR, spreadsheets, and manual outreach
Initial costSubscription plus implementation and integration workLower software spending, but staff and management time remain substantial
ScalingDesigned for multiple clinics, teams, and standardized workflowsEach location develops its own process and may need separate audits
MeasurementCommon definitions, dashboards, reminders, and action queuesMetrics may be inconsistent, delayed, or limited to individual spreadsheets
Clinical safetyUsually requires governance, access controls, consent handling, and monitoringData stays in familiar systems, but manual follow-up can be missed
FlexibilityConfigurable journeys, thresholds, roles, and escalation rulesEasy to change locally, but difficult to govern across a network
Best fitOrganizations seeking consistent pulse monitoring and closed-loop coordinationSmall teams testing demand before committing to a platform
The preferred choice depends on scale, workflow complexity, technical capacity, and the cost of inconsistent execution. A hybrid approach can be sensible: keep sensitive clinical data inside approved systems, send only the minimum necessary signal to the coordination layer, and assign human review before escalation.

Plan a practical 6–12 month implementation

The first phase should be discovery and baseline measurement, usually lasting two to four weeks. During this period, stakeholders map the current workflow, interview staff and patients, identify the decision to be improved, and validate data definitions. They should also conduct security, privacy, and integration reviews early because late discoveries can invalidate the economics. A narrow pilot involving one high-burden pathway is usually safer than enrolling every patient immediately, especially when staff already face competing initiatives.

The second phase can be a 60–90 day pilot with a defined cohort. One practical threshold is to include 250–500 patients or episodes when volume permits, with enough events to compare the new process against baseline behavior. The team should establish role-based access, escalation rules, downtime procedures, response-time standards, and weekly adoption reviews. A pilot is successful only when the software is connected to a person who can act on a concerning signal; merely collecting more responses is not enough.

The third phase should last three to six months and test durability. Track whether outreach rates improve, false positives are tolerable, staff response times remain acceptable, and patients experience the program as useful rather than burdensome. At approximately month six, the sponsor can expand, renegotiate, or stop based on pre-agreed evidence. By month 12, the network should be able to estimate annualized value, operating cost, and the effect of scaling across additional clinics. Expansion should be conditional on stable workflow performance, support capacity, and documented data quality rather than enthusiasm alone.

Estimate cost and pricing without hiding the operating burden

Planning figures should be labeled as estimates because actual pricing depends on users, sites, patient volume, integrations, support, security requirements, and contract structure. A small clinic may test a narrow workflow with an annual subscription in the low five figures after implementation, while a multi-site network with multiple integrations, custom reporting, and dedicated support can face tens or hundreds of thousands of dollars annually. These are planning ranges, not quotes from getpulse.care, and a proposal should state exactly what each figure includes.

The proposal should separate one-time and recurring costs. One-time costs commonly include discovery, configuration, data mapping, integration, security review, training, and patient-facing material. Recurring costs may include licenses, infrastructure, premium support, analytics, governance, and administrative account management. Hidden costs include staff time for weekly adoption meetings, manual data correction, report interpretation, and managing patient questions. A buyer should also ask whether a 20% patient-volume increase changes price, whether inactive seats can be reassigned, and what happens if the network loses a contracted site.

A useful decision threshold is payback within 12–18 months for a clearly measurable workflow, or a faster threshold for a high-risk compliance or safety use case. The network should not accept a long payback simply because the vendor labels a feature “strategic.” Conversely, a project with strong clinical value may reasonably proceed without immediate cash savings if accountable leaders define how that value will be measured and used. The business case is stronger when it includes both a financial scenario and a nonfinancial operating scenario, with the uncertainty shown in each.

Avoid common implementation mistakes

The most frequent mistake is beginning with a feature catalog instead of a service problem. Buying dashboards, automated messages, and risk scores does not guarantee better coordination. The team should first define the action that must happen, who has authority to take it, what information is necessary, and how completion will be recorded. If those answers are unclear, the software will merely add another inbox.

Another mistake is assuming that higher response rates equal better care. A high pulse-response rate can reflect broad outreach, while a low rate may indicate that a small group needs more attention. Metrics should be risk-adjusted or interpreted alongside demographics, clinical context, and accessibility barriers. Teams should also avoid escalating every abnormal result; excessive alerts can create fatigue and cause staff to ignore important signals. Thresholds should be tested against false-positive burden and adjusted with clinical governance.

Data practices are another common failure point. Collecting sensitive information without a clear purpose, retaining it longer than needed, or making it visible to unauthorized staff can create privacy and security risk. Networks should apply least-privilege access, audit logging, encryption appropriate to the environment, documented retention, and a process for data correction or deletion where applicable. A further mistake is launching without a downtime plan, so a temporary integration failure does not interrupt urgent care or prevent staff from documenting outreach elsewhere.

Finally, the network should resist unrealistic adoption goals. A 90-day pilot cannot prove every long-term clinical outcome, and an 80% response rate may be inappropriate for some populations. Set thresholds that the evidence can support, such as at least 70% of assigned users completing training, 85% of actionable messages receiving an owner within one business day, or a 15% reduction in overdue follow-ups. The exact target should reflect baseline performance and the pathway involved, not a generic industry benchmark.

When to act, revise, or stop

Act quickly when a network can name a costly, repeated coordination problem, has access to reliable patient and operational data, and has an owner who can change the workflow. A good early signal is that staff are exporting referrals into spreadsheets, repeatedly searching for the latest patient status, or unable to tell whether an outreach task was completed. A second signal is a leadership initiative with measurable targets, such as improving post-discharge follow-up or reducing unexplained missed appointments. In these situations, a 90-day evidence pilot can produce a decision faster than a lengthy software replacement program.

Revise the plan when usage is high but outcomes are weak. The team may have configured the wrong thresholds, targeted the wrong cohort, or failed to provide enough staffing for outreach. It may also have measured activity without measuring the intended result. Before expanding, determine whether the problem is technical, clinical, operational, or financial, and then change one major factor at a time where possible. Reasonable thresholds for a revision might be fewer than 60% of high-priority items acknowledged within two business days, persistent data-completion errors above 5%, or staff reporting that alerts are not actionable.

Stop or narrow the project when benefits cannot be demonstrated after a fair test and process owners do not believe the workflow is sustainable. This is not a failure if the organization has learned that its actual bottleneck is staffing, contracting, or upstream data quality rather than software. The network should also pause expansion when a pilot creates unresolved security concerns, unexplained clinical escalation patterns, or patient confusion. A credible proposal is not one that promises universal success; it is one that specifies what evidence would cause the organization to stop.

The best business case therefore combines a narrow problem, measurable baseline, conservative economics, and staged commitment. It recognizes that care coordination is a human service supported by software, not a replacement for clinical judgment. For getpulse.care, the strongest position is to help clinics and care networks see patient pulse signals, coordinate actions, and learn from outcomes without claiming that a platform alone guarantees lower costs or better health. As of 26 September 2026, that evidence-based stance is commercially more defensible than an aggressive promise of transformation.